Search Results

There are 4687 results for: content related to: Moving past “One Size (and Number) Fits All” in the selection of candidates with hepatocellular carcinoma for liver transplantation

  1. You have free access to this content
    Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1111–1121, Adeel R. Seyal, Fernanda D. Gonzalez-Guindalini, Atilla Arslanoglu, Carla B. Harmath, Robert J. Lewandowski, Riad Salem and Vahid Yaghmai

    Version of Record online : 19 JUN 2015, DOI: 10.1002/hep.27915

  2. Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation

    Liver Transplantation

    Volume 22, Issue 11, November 2016, Pages: 1491–1500, Marco Dioguardi Burgio, Maxime Ronot, Onorina Bruno, Claire Francoz, Valérie Paradis, Laurent Castera, François Durand, Olivier Soubrane and Valérie Vilgrain

    Version of Record online : 26 OCT 2016, DOI: 10.1002/lt.24615

  3. You have free access to this content
    Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 147–156, Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul

    Version of Record online : 28 JUN 2011, DOI: 10.1002/cncr.26255

  4. You have free access to this content
    Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation

    Liver Transplantation

    Volume 19, Issue 10, October 2013, Pages: 1108–1118, Quirino Lai, Alfonso W. Avolio, Ivo Graziadei, Gerd Otto, Massimo Rossi, Giuseppe Tisone, Pierre Goffette, Wolfgang Vogel, Michael B. Pitton, Jan Lerut and on behalf of the European Hepatocellular Cancer Liver Transplant Study Group

    Version of Record online : 24 SEP 2013, DOI: 10.1002/lt.23706

  5. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  6. mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib

    International Journal of Cancer

    Volume 140, Issue 2, 15 January 2017, Pages: 390–399, Wenjun Wang, Wei Bai, Enxin Wang, Yan Zhao, Lei Liu, Man Yang, Hongwei Cai, Dongdong Xia, Lei Zhang, Jing Niu, Zhanxin Yin, Zhuoli Zhang, Daiming Fan, Jielai Xia and Guohong Han

    Version of Record online : 17 OCT 2016, DOI: 10.1002/ijc.30451

  7. Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer

    HPB

    Volume 17, Issue 12, December 2015, Pages: 1085–1095, Quirino Lai, Milton Inostroza, Juan M. Rico Juri, Pierre Goffette and Jan Lerut

    Version of Record online : 16 SEP 2015, DOI: 10.1111/hpb.12486

  8. You have free access to this content
    Downstaging hepatocellular carcinoma: A systematic review and pooled analysis

    Liver Transplantation

    Volume 21, Issue 9, September 2015, Pages: 1142–1152, Neehar D. Parikh, Akbar K. Waljee and Amit G. Singal

    Version of Record online : 25 AUG 2015, DOI: 10.1002/lt.24169

    Corrected by:

    Erratum: Erratum: Downstaging hepatocellular carcinoma: A systematic review and pooled analysis

    Vol. 22, Issue 1, 138, Version of Record online: 28 DEC 2015

  9. You have free access to this content
    Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria

    Liver Transplantation

    Volume 20, Issue 8, August 2014, Pages: 945–951, Bilal Hameed, Neil Mehta, Gonzalo Sapisochin, John P. Roberts and Francis Y. Yao

    Version of Record online : 12 JUL 2014, DOI: 10.1002/lt.23904

  10. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  11. Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy

    Journal of Surgical Oncology

    Volume 113, Issue 4, March 15, 2016, Pages: 443–448, Olaguoke Akinwande, Prejesh Philips, Charles R. Scoggins, Lawrence Kelly, Cliff Tatum, Mike Hahl, Kelly M. McMasters and Robert C.G. Martin

    Version of Record online : 6 APR 2016, DOI: 10.1002/jso.24141

  12. Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 305–312, Chang Joon Kim, Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim and Min-Ji Kim

    Version of Record online : 25 JUL 2013, DOI: 10.1111/liv.12270

  13. You have free access to this content
    Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation

    Liver Transplantation

    Volume 21, Issue 5, May 2015, Pages: 599–606, Roongruedee Chaiteerakij, Xiaodan Zhang, Benyam D. Addissie, Essa A. Mohamed, William S. Harmsen, Paul J. Theobald, Brian E. Peters, Joseph G. Balsanek, Melissa M. Ward, Nasra H. Giama, Catherine D. Moser, Abdul M. Oseini, Naoki Umeda, Sudhakar Venkatesh, Denise M. Harnois, Michael R. Charlton, Hiroyuki Yamada, Shinji Satomura, Alicia Algeciras-Schimnich, Melissa R. Snyder, Terry M. Therneau and Lewis R. Roberts

    Version of Record online : 24 APR 2015, DOI: 10.1002/lt.24117

  14. You have free access to this content
    Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1655–1666, Michael Vouche, Laura Kulik, Rohi Atassi, Khairuddin Memon, Ryan Hickey, Daniel Ganger, Frank H. Miller, Vahid Yaghmai, Michael Abecassis, Talia Baker, Mary Mulcahy, Ritu Nayar, Robert J. Lewandowski and Riad Salem

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26487

  15. You have free access to this content
    Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria

    Hepatology

    Volume 61, Issue 6, June 2015, Pages: 1968–1977, Francis Y. Yao, Neil Mehta, Jennifer Flemming, Jennifer Dodge, Bilal Hameed, Oren Fix, Ryutaro Hirose, Nicholas Fidelman, Robert K. Kerlan Jr. and John P. Roberts

    Version of Record online : 20 MAR 2015, DOI: 10.1002/hep.27752

  16. You have free access to this content
    Recurrence of Hepatocellular Carcinoma: Importance of mRECIST Response to Chemoembolization and Tumor Size

    American Journal of Transplantation

    Volume 14, Issue 6, June 2014, Pages: 1383–1390, D. J. Kim, P. J. Clark, J. Heimbach, C. Rosen, W. Sanchez, K. Watt and M. R. Charlton

    Version of Record online : 6 MAY 2014, DOI: 10.1111/ajt.12684

  17. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study

    Journal of Magnetic Resonance Imaging

    Volume 42, Issue 4, October 2015, Pages: 981–989, Nima Kokabi, Juan C. Camacho, Minzhi Xing, Faramarz Edalat, Pardeep K. Mittal and Hyun S. Kim

    Version of Record online : 12 FEB 2015, DOI: 10.1002/jmri.24845

  18. Serum cell death biomarker mirrors liver cancer regression after transarterial chemoembolisation

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 747–754, B. Bock, D. Hasdemir, F. Wandrer, T. Rodt, M. P. Manns, K. Schulze-Osthoff and H. Bantel

    Version of Record online : 3 AUG 2016, DOI: 10.1111/apt.13758

  19. You have free access to this content
    Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma

    Liver Transplantation

    Volume 21, Issue 10, October 2015, Pages: 1259–1269, Matteo Angelo Manini, Angelo Sangiovanni, Laura Martinetti, Davide Viganò, Vincenzo La Mura, Alessio Aghemo, Massimo Iavarone, Silvia Crespi, Antonio Nicolini and Massimo Colombo

    Version of Record online : 29 SEP 2015, DOI: 10.1002/lt.24196

  20. Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography

    Hepatology Research

    Volume 45, Issue 9, September 2015, Pages: 976–985, Hisashi Hidaka, Takahide Nakazawa, Shigeru Fujii, Michiko Yanagihara, Tsutomu Minamino, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Akitaka Shibuya and Wasaburo Koizumi

    Version of Record online : 11 DEC 2014, DOI: 10.1111/hepr.12440